Clinical Study to Determine Safety and Efficacy of FPlus for Wrinkle Treatment

Inclusion Criteria: * Subjects with mild to moderate facial wrinkles and rhytides . * Males and females 21 - 65 years of age. * Willingness to follow the treatment schedule, and have photographs taken. Exclusion Criteria: * Pacemaker or internal defibrillator, or other implanted metallic or electronic device. * Permanent implant in the treated area such as metal plates and screws or silicon, unless deep enough in the periosteal plane. * Avoid treatment if intra-dermal or superficial sub-dermal areas have been injected with Botox/HA/collagen/fat injections or other augmentation methods with bio-material during last 6 months. * Current or history of skin cancer, or any other type of cancer, or pre-malignant moles. * Severe concurrent conditions, such as cardiac disorders. * Pregnancy or nursing. * Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications. * Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regime. * Poorly controlled endocrine disorders, such as diabetes. * Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash. * History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin. * History of bleeding coagulopathies, or use of anticoagulants in the last 10 days. * Any facial surgery performed within 12 months prior to treatment. * Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last 3 months. * Having received treatment with light, laser, RF, or other devices in the treated area within 6 months. * Use of Isotretinoin (Accutane®) within 6 months prior to treatment. * Treating over tattoo or permanent makeup. * As per the practitioner's discretion, refrain from treating any condition that might make it unsafe for the patient.